Specifically, active compounds in CHM have been shown to attenuate inflammation mediated by key cytokines, such as interleukin and tumor necrosis factor, both of which are critical in the pathogenesis of osteoarthritis-associated pain (13, 85). This evidence concerns the gene TNF and osteoarthritis.